Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Sanofi : MILITARY $3.2 Million Federal Contract Awarded to Sanofi Pasteur

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/13/2017 | 01:44pm CET

By Targeted News Service

PHILADELPHIA, Jan. 13 -- Sanofi Pasteur Inc., Swiftwater, Pennsylvania, won a $3,203,163.15 federal contract from the Defense Logistics Agency for meningococcal polysaccharide vaccines.

For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897.

22LapigM 170112-949400 30VitinMar

(c) 2017 Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
01/13 SANOFI : MILITARY $3.2 Million Federal Contract Awarded to Sanofi Pasteur
01/13 SANOFI : MILITARY $526,056 Federal Contract Awarded to Sanofi Pasteur
01/13 SANOFI : MILITARY $1.85 Million Federal Contract Awarded to Sanofi Pasteur
01/13 SANOFI : MILITARY $192,418 Federal Contract Awarded to Sanofi Pasteur
01/12 SANOFI : and Boehringer Ingelheim Confirm Closing of Business Swap on January 1s..
01/12 SANOFI : Announces Soliqua 100/33 Now Available in the U.S.
01/10 SANOFI : Sedalia losing a mile of the Katy Trail
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/10 SANOFI : Amgen Issues Statement On Court Decision On Patent Litigation
01/09 SANOFI : Disclosure of trading in own shares
More news
Sector news : Pharmaceuticals - NEC
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/13DJLONDON MARKETS : FTSE 100 Continues Record Run, Rising For 14th Day In A Row
01/13 FTSE hits record highs, extends historic winning streak
01/12DJCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- Update
01/12 Investors in big pharma, biotech look to ride out Trump storm
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/13 SANOFI : Key Threats In 2017 And Beyond
01/13 BIOTECHS : What The 'Trump Dump' And CVS's EpiPen Move May Mean
01/12 CLIMATE CHANGE INVESTING : Up In The Air
01/12 Will 2017 Be Different For Gilead Sciences
01/11 Why Regeneron May Have Lots Of Growth Ahead
Advertisement
Financials (€)
Sales 2016 36 746 M
EBIT 2016 9 191 M
Net income 2016 5 242 M
Debt 2016 6 114 M
Yield 2016 3,75%
P/E ratio 2016 17,16
P/E ratio 2017 15,36
EV / Sales 2016 2,91x
EV / Sales 2017 2,91x
Capitalization 100 868 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 81,0 €
Spread / Average Target 3,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI1.52%107 323
JOHNSON & JOHNSON-0.53%311 773
ROCHE HOLDING LTD.2.75%204 641
PFIZER INC.0.12%197 343
NOVARTIS AG-1.48%189 749
MERCK & CO., INC.5.89%171 880
More Results